Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg
Clinical trial NCT00751036 · TERMINATED
Trial details
- NCT number
- NCT00751036
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2012-08-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.